190 related articles for article (PubMed ID: 20886224)
1. Long-term outcome after treatment with 5% topical imiquimod cream in patients with basal cell carcinoma of the eyelids.
Prokosch V; Thanos S; Spaniol K; Stupp T
Graefes Arch Clin Exp Ophthalmol; 2011 Jan; 249(1):121-5. PubMed ID: 20886224
[TBL] [Abstract][Full Text] [Related]
2. Treatment of basal cell carcinoma of the eyelids with 5% topical imiquimod: a 3-year follow-up study.
Choontanom R; Thanos S; Busse H; Stupp T
Graefes Arch Clin Exp Ophthalmol; 2007 Aug; 245(8):1217-20. PubMed ID: 17345092
[TBL] [Abstract][Full Text] [Related]
3. Immunotherapy with imiquimod 5% cream for eyelid nodular basal cell carcinoma.
Blasi MA; Giammaria D; Balestrazzi E
Am J Ophthalmol; 2005 Dec; 140(6):1136-9. PubMed ID: 16376667
[TBL] [Abstract][Full Text] [Related]
4. Imiquimod 5% cream for the treatment of periocular Basal cell carcinoma.
Carneiro RC; de Macedo EM; Matayoshi S
Ophthalmic Plast Reconstr Surg; 2010; 26(2):100-2. PubMed ID: 20305508
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of topical 5% imiquimod cream for the treatment of nodular basal cell carcinoma: comparison of dosing regimens.
Shumack S; Robinson J; Kossard S; Golitz L; Greenway H; Schroeter A; Andres K; Amies M; Owens M
Arch Dermatol; 2002 Sep; 138(9):1165-71. PubMed ID: 12224977
[TBL] [Abstract][Full Text] [Related]
6. Topical imiquimod treatment for nodular basal cell carcinomas: an open-label series.
Huber A; Huber JD; Skinner RB; Kuwahara RT; Haque R; Amonette RA
Dermatol Surg; 2004 Mar; 30(3):429-30. PubMed ID: 15008876
[TBL] [Abstract][Full Text] [Related]
7. Open study of the efficacy and mechanism of action of topical imiquimod in basal cell carcinoma.
Vidal D; Matías-Guiu X; Alomar A
Clin Exp Dermatol; 2004 Sep; 29(5):518-25. PubMed ID: 15347339
[TBL] [Abstract][Full Text] [Related]
8. Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial.
Arits AH; Mosterd K; Essers BA; Spoorenberg E; Sommer A; De Rooij MJ; van Pelt HP; Quaedvlieg PJ; Krekels GA; van Neer PA; Rijzewijk JJ; van Geest AJ; Steijlen PM; Nelemans PJ; Kelleners-Smeets NW
Lancet Oncol; 2013 Jun; 14(7):647-54. PubMed ID: 23683751
[TBL] [Abstract][Full Text] [Related]
9. Long-Term Follow-Up Results of Topical Imiquimod Treatment in Basal Cell Carcinoma.
Bostanci S; Kocyigit P; Vural S; Heper AO; Botsali A
Dermatol Surg; 2018 Jan; 44(1):36-41. PubMed ID: 29016542
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and tolerability of imiquimod 5% cream to treat periocular basal cell carcinomas.
Garcia-Martin E; Idoipe M; Gil LM; Pueyo V; Alfaro J; Pablo LE; Zubiri ML; Fernandez J
J Ocul Pharmacol Ther; 2010 Aug; 26(4):373-9. PubMed ID: 20698800
[TBL] [Abstract][Full Text] [Related]
11. Topical imiquimod therapy for basal and squamous cell carcinomas: a clinical experience.
Tillman DK; Carroll MT
Cutis; 2007 Mar; 79(3):241-8. PubMed ID: 17674590
[TBL] [Abstract][Full Text] [Related]
12. Imiquimod in the treatment of eyelid basal cell carcinoma.
Leppälä J; Kaarniranta K; Uusitalo H; Kontkanen M
Acta Ophthalmol Scand; 2007 Aug; 85(5):566-8. PubMed ID: 17376190
[TBL] [Abstract][Full Text] [Related]
13. Imiquimod 5% cream for the treatment of large nodular basal cell carcinoma at the medial canthal area.
Karabulut GO; Kaynak P; Ozturker C; Fazil K; Ocak OB; Taskapılı M
Indian J Ophthalmol; 2017 Jan; 65(1):48-51. PubMed ID: 28300740
[TBL] [Abstract][Full Text] [Related]
14. Imiquimod 5% cream for the treatment of superficial and nodular basal cell carcinoma: randomized studies comparing low-frequency dosing with and without occlusion.
Sterry W; Ruzicka T; Herrera E; Takwale A; Bichel J; Andres K; Ding L; Thissen MR
Br J Dermatol; 2002 Dec; 147(6):1227-36. PubMed ID: 12452875
[TBL] [Abstract][Full Text] [Related]
15. Treatment of cutaneous tumors with topical 5% imiquimod cream.
Alessi SS; Sanches JA; Oliveira WR; Messina MC; Pimentel ER; Festa Neto C
Clinics (Sao Paulo); 2009; 64(10):961-6. PubMed ID: 19841702
[TBL] [Abstract][Full Text] [Related]
16. The SINS trial: a randomised controlled trial of excisional surgery versus imiquimod 5% cream for nodular and superficial basal cell carcinoma.
Ozolins M; Williams HC; Armstrong SJ; Bath-Hextall FJ
Trials; 2010 Apr; 11():42. PubMed ID: 20409337
[TBL] [Abstract][Full Text] [Related]
17. Imiquimod cream efficacy in the treatment of periocular nodular basal cell carcinoma: a non-randomized trial.
de Macedo EM; Carneiro RC; de Lima PP; Silva BG; Matayoshi S
BMC Ophthalmol; 2015 Apr; 15():35. PubMed ID: 25885553
[TBL] [Abstract][Full Text] [Related]
18. Surgical excision versus imiquimod 5% cream for nodular and superficial basal-cell carcinoma (SINS): a multicentre, non-inferiority, randomised controlled trial.
Bath-Hextall F; Ozolins M; Armstrong SJ; Colver GB; Perkins W; Miller PS; Williams HC;
Lancet Oncol; 2014 Jan; 15(1):96-105. PubMed ID: 24332516
[TBL] [Abstract][Full Text] [Related]
19. Topical imiquimod or fluorouracil therapy for basal and squamous cell carcinoma: a systematic review.
Love WE; Bernhard JD; Bordeaux JS
Arch Dermatol; 2009 Dec; 145(12):1431-8. PubMed ID: 20026854
[TBL] [Abstract][Full Text] [Related]
20. Pilot study using topical imiquimod 5% cream in the treatment of nodular basal cell carcinoma after initial treatment with curettage.
Neville JA; Williford PM; Jorizzo JL
J Drugs Dermatol; 2007 Sep; 6(9):910-4. PubMed ID: 17941362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]